Connect with us

Technology

Multiple New Awards Recognize NCCN as Exceptional Source for Information for Cancer Patients and Caregivers

Published

on

NCCN Guidelines for Patients earn Hermes Award for electronic media and Communicator Award for medical print content.

NCCN Patient Webinars earns Digital Health Award and Viddy Award for outstanding achievement in video and digital production.

PLYMOUTH MEETING, Pa., June 17, 2024 /PRNewswire/ — The National Comprehensive Cancer Network® (NCCN®) today announced new recognitions for the award-winning library of NCCN Guidelines for Patients® and NCCN Patient Webinars. The NCCN Guidelines for Patients: Colon Cancer earned a Gold Award from Hemes Creative Awards for Electronic Media/Social Media/Interactive Media/Digital Publications/Messaging. The NCCN Guidelines for Patients: Kidney Cancer earned an Award of Distinction from The Communicator Awards for Print Content—Medical. Additionally, the NCCN Patient Webinar for Uterine Cancer has been named a Gold Winner from the Viddy Awards while the NCCN Patient Webinar for Inflammatory Breast Cancer earned a Silver Digital Health Award.

The library of NCCN Guidelines for Patients includes more than 70 books providing people with cancer and their loved ones with easy-to-understand information about prevention, screening, diagnosis, treatment, and supportive care for nearly every type of cancer. They are based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—which are continuously updated, evidence-based, expert consensus-driven recommendations that inform cancer care treatment decisions worldwide.

The NCCN Guidelines for Patients are available to view or download for free online at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App, thanks to funding from the NCCN Foundation®. Printed versions are available for a nominal fee at Amazon.com.

“High-quality patient-centered care can only be achieved when patients and caregivers are properly informed about their options,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. “We are incredibly proud of the work we do to provide understandable, trustworthy, up-to-date information based on the highest possible standards of research and multidisciplinary subject matter expertise. The growing list of awards for the NCCN Guidelines for Patients and NCCN Patient Webinars recognize the skill and care our patient information team puts into everything they do.”

The Hermes Creative Awards are administered and judged by the Association of Marketing and Communication Professionals (AMCP). 2024 saw more than 6,500 entries worldwide across 200 categories. The 30th Annual Communicator Awards were overseen by the Academy of Interactive and Visual Arts (AIVA). There were more than 3,000 entries this year vying for recognition in various communication and design categories.

The NCCN Guidelines for Patients have previously earned Digital Health Awards, an APEX Award, and an Excellence in Cancer Patient Education Award. Independent studies have listed them among top global sources for trustworthy online information about cancer.

“These resources put expert-vetted cancer-related information in the hands of people with, or at risk of, cancer everywhere,” said Patrick Delaney, Executive Director, NCCN Foundation. “We work diligently to ensure our patient guidelines are accessible to the millions of people who utilize them around the world. They have been translated into numerous languages, and include a glossary of terms, pictures and diagrams, and suggested questions to ask. Our webinars present the same information in a way that is more accessible to people who prefer interactive discussion and video. It is a tremendous honor to see our various efforts be recognized in this way.”

NCCN’s free patient and caregiver webinars cover a variety of cancer-related topics in multiple languages—through funding from the NCCN Foundation. The NCCN Webinar for Patients: Early-Stage Prostate Cancer was also a Digital Health Gold award recipient last year.

To learn about upcoming patient webinars and view recorded presentations, visit NCCN.org/patientwebinars. To help support NCCN patient guidelines, patient webinars, and other free resources for people with cancer and their caregivers, visit NCCN.org/foundation.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

About the NCCN Foundation
The NCCN Foundation empowers people with cancer and their caregivers by delivering unbiased expert guidance from the world’s leading cancer experts through the library of NCCN Guidelines for Patients® and other patient education resources. The NCCN Foundation is also committed to advancing cancer treatment by funding the nation’s promising young investigators at the forefront of cancer research. For more information about the NCCN Foundation, visit nccnfoundation.org.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

 

SOURCE National Comprehensive Cancer Network

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CBIZ TO ANNOUNCE FIRST-QUARTER 2025 RESULTS ON APRIL 24, 2025

Published

on

By

CLEVELAND, April 16, 2025 /PRNewswire/ — CBIZ, Inc. (NYSE: CBZ) (the “Company”), a leading national professional services advisor, will announce its financial results for the first quarter ended March 31, 2025, before markets open on Thursday, April 24, 2025.

A conference call to discuss the Company’s financial results will be hosted by CBIZ President and Chief Executive Officer Jerry Grisko and Chief Financial Officer Brad Lakhia at 11 a.m. (ET) on Wednesday, April 24, 2025. The conference call will be webcast live on the investor relations page of the CBIZ website at https://cbiz.gcs-web.com/investor-overview.

An archived replay of the webcast will be available following the conclusion of the call.

Investors can register at https://dpregister.com/sreg/10198710/fee4c9dc2a to receive the dial-in number and a unique personal identification number. Participants may register at any time, including up to and after the call start time.

About CBIZ
CBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle-market businesses nationwide. With industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers actionable insights to help clients anticipate what is next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit www.cbiz.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cbiz-to-announce-first-quarter-2025-results-on-april-24-2025-302430901.html

SOURCE CBIZ, Inc.

Continue Reading

Technology

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

Published

on

By

PARIS, April 16, 2025 /PRNewswire/ — On the second day of an official visit to France, His Excellency Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, held bilateral meetings with senior French officials including Minister for Labour, Health, Solidarity and Families Catherine Vautrin, Minister for Health and Access to Care Yannick Neuder and Laurent Saint-Martin, Minister Delegate for Foreign Trade and French Nationals Abroad.

Discussions focused on strengthening cooperation in health innovation, research, workforce development, investment promotion, and supply chain resilience, aligned with the Kingdom’s Vision 2030 Health Sector Transformation.

A highlight of the visit was the signing of several agreements, witnessed by Their Excellencies, designed to strengthen and expand the health partnership between Saudi Arabia and France. The first between Seha Virtual Hospital and Gustave Roussy aims to enhance cancer care and digital health through AI-powered telemedicine.

Another, signed between the Health Holding Company (HHC) and France Biotech, focuses on accelerating the development of the Health Tech and Life Sciences ecosystems in both countries by supporting healthcare startups and promoting the integration of innovative technologies.

A third agreement, between the Saudi Red Crescent Authority and Assistance publique-hôpitaux de Paris, will strengthen cooperation in Emergency Medical Services, including joint training, knowledge exchange, and best practices in emergency response.

His Excellency Minister Aljalajel stated: “I welcome the strengthening of these collaborative ties with France’s leading institutions, which reflect our commitment to advancing excellence and innovation across the health sector. These partnerships not only strengthen international ties but also position the Kingdom of Saudi Arabia as a dynamic and innovation-friendly ecosystem – one that is actively attracting global innovators and creating significant opportunities for transformative impact within our evolving healthcare landscape. They represent an important step forward in achieving the goals of Vision 2030, as we continue to transform our health system to deliver world-class care and foster a thriving life sciences sector.”

The Minister’s three-day visit to Paris and Lyon demonstrates the shared commitment of Saudi Arabia and France to enhance healthcare services and innovation, while further strengthening their bilateral relationship in support of global health goals.

Photo – https://mma.prnewswire.com/media/2666968/Ministry_of_Health_Saudi_Arabia.jpg

View original content:https://www.prnewswire.co.uk/news-releases/saudi-arabia-and-france-strengthen-health-cooperation-through-strategic-agreements-in-biotech-and-digital-health-302430909.html

Continue Reading

Technology

Court Grants Final Order to Converge Approving Acquisition by H.I.G. Capital

Published

on

By

TORONTO and GATINEAU, QC, April 16, 2025 /CNW/ – Converge Technology Solutions Corp. (“Converge” or the “Company”) (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) announced today that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement (the “Arrangement”) involving the Company and 16728421 Canada Inc. (the “Purchaser”), an affiliate of H.I.G. Capital (“H.I.G.”) pursuant to which the Purchaser will acquire all of the issued and outstanding common shares in the capital of Converge (the “Shares”), other than certain Shares held by certain shareholders who entered into rollover equity agreements.

Subject to the satisfaction or waiver, where permitted, of the remaining conditions to closing contained in the arrangement agreement entered into between the Company and the Purchaser dated February 6, 2025, as amended by the amending agreement dated April 1, 2025 (collectively, the “Arrangement Agreement”), it is anticipated that the Arrangement will be completed by the parties on or about April 22, 2025.

The Company also announced that all regulatory approvals necessary for completion of the Arrangement have now been obtained.

Questions for Depositary

Shareholders who have questions or require assistance submitting their Shares in connection with the Arrangement may direct their questions to Computershare Investor Services Inc., which is acting as depositary in connection with the Arrangement, at 1-800-564-6253 (toll-free within North America) or 1-514-982-7555 (outside of North America) or by email at corporateactions@computershare.com.

About Converge

Converge Technology Solutions Corp. is reimagining the way businesses think about IT—a vision driven by people, for people. Since 2017, we’ve focused on delivering outcomes-driven solutions that tackle human- centered challenges. As a services-led, software-enabled, IT & Cloud Solutions provider, we combine deep expertise, local connections, and global resources to deliver industry-leading solutions.

Through advanced analytics, artificial intelligence (AI), cloud platforms, cybersecurity, digital infrastructure, and workplace transformation, we empower businesses across industries to innovate, streamline operations, and achieve meaningful results. Our AIM (Advise, Implement, Manage) methodology ensures solutions are tailored to our customers’ specific needs, aligning with existing systems to drive success without complexity.

Discover IT reimagined with Converge—where innovation meets people. Learn more at convergetp.com.

Forward-Looking Information

This press release contains certain “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation regarding Converge and its business. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected” “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”. “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

Specifically, statements regarding the completion of the Arrangement and other statements that are not statements of historical facts are considered forward-looking information. The anticipated dates indicated may change for a number of reasons, including the necessity to extend the time limits for satisfying the other conditions for the completion of the Arrangement. The forward-looking information are based on management’s opinions, estimates and assumptions. While these opinions, estimates and assumptions are considered by the Company to be appropriate and reasonable in the circumstances as of the date of this press release, they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking information.

The forward-looking information are subject to significant risks including, without limitation: risks relating to the completion of the Arrangement and general economic conditions.

If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward- looking information contained in this press release represents the Company’s expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information or to publicly announce the results of any revisions to any of those statements, whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/court-grants-final-order-to-converge-approving-acquisition-by-hig-capital-302430926.html

SOURCE Converge Technology Solutions Corp.

Continue Reading

Trending